The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Ivanets N.N.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Kinkul'kina M.A.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Tikhonova Iu.G.

Kafedra psikhiatrii i narkologii GBOU VPO "Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova" Minzdrava RF;
Nauchno-obrazovatel'nyĭ klinicheskiĭ tsentr "Psikhicheskoe zdorov'e", Moskva

Avdeeva T.I.

The current state and future prospects of depression research (clinical and classification problems)

Authors:

Ivanets N.N., Kinkul'kina M.A., Tikhonova Iu.G., Avdeeva T.I.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(10): 76‑81

DOI: 10.17116/jnevro201811810176

Views: 1290

Downloaded: 66

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Ivanets NN, Kinkul'kina MA, Tikhonova IuG, Avdeeva TI. The current state and future prospects of depression research (clinical and classification problems). S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(10):76‑81. (In Russ.)
https://doi.org/10.17116/jnevro201811810176

 
МСФ на ЯМ
Close metadata
Recommended articles:
The asso­ciation of poly­morphisms of the sero­tonin transporter gene SLC6A4 with depression. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(2):135-139
The effect of inso­mnia on mild cognitive impairment in patients with vascular risks: resu­lts of a three-year longitudinal study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):30-36
A perspective on the application of CRISPR/CAS9 genome editing system to study of mole­cular-genetic basis of mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):27-33
Vali­dation of screening method based on EEG analysis for the risk asse­ssment of psychiatric and beha­vioral diso­rders: a pilot study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):88-96
A clinical case of the new-onset bipo­lar affe­ctive diso­rder in the postcovid period. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):125-129
Pathogenetic basis of modern approaches to the therapy of sleep diso­rders in the clinic of depression. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):69-74
Features of the clinical picture of affe­ctive diso­rders in women during the meno­pausal transition and early postmenopause. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):75-79
Targeting NMDAR/AMPAR: a promising pharmacotherapeutic approach for depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):22-30
Asthenia in young patients and possibilities for its correction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):133-137
The asso­ciation between myopia and glaucoma. Russian Annals of Ophthalmology. 2024;(1):93-98

Despite decades of research, neurobiological studies of depression haven’t achieved significant results. Many experts propose that one of the main reasons for this failure is current diagnostic standards not considering the heterogeneity and polymorphism of depression. Research is unable to identify specific neurobiological changes due to formal diagnosis «major depressive disorder» and new diagnostic criteria are needed. RDoC (Research Domain Criteria) has intensified the confrontation between biological and clinical researchers and changes in approach to depressive psychopathology are discussed. A review presents the recent approaches used in studies of depressive disorders, the methodology they use, the scientific paradigms they rely on.

Keywords:

depression
diagnostic criteria
classification of depression
symptom-based approach
network analysis
RDoC
HiTOP

Authors:

Ivanets N.N.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Kinkul'kina M.A.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Tikhonova Iu.G.

Kafedra psikhiatrii i narkologii GBOU VPO "Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova" Minzdrava RF;
Nauchno-obrazovatel'nyĭ klinicheskiĭ tsentr "Psikhicheskoe zdorov'e", Moskva

Avdeeva T.I.

List of references:

  1. Fried EI. Problematic assumptions have slowed down depression research: why symptoms, not syndromes are the way forward. Front Psychol. 2015;6:309. https://doi.org/10.3389/fpsyg.2015.00309
  2. Kapur S, Phillips AG, Insel TR. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol Psychiatry. 2012;17:1174-1179. https://doi.org/10.1038/mp.2012.105
  3. Strawbridge et al. Biomarkers for depression: recent insights, current challenges and future prospects. Neuropsychiatric Disease and Treatment. 2017:13: 1245-1262. https://doi.org/10.2147/NDT.S114542
  4. Amare AT, Schubert KO, Baune BT. Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry. EPMA Journal. 2017;8:211-227. https://doi.org/10.1007/s13167-017-0112-8
  5. O’Neil A, Quirk SE, Housden SL, et al. The relationship between diet and mental health in children and adolescents: a systematic review. Am J Public Health. 2014;104:31-42. https://doi.org/10.2105/ajph.2014.302110
  6. Psaltopoulou T, Sergentanis TN, Panagiotakos DB, et al. Mediterranean diet, stroke, cognitive impairment, and depression: a metaanalysis. Ann Neurol. 2013;74:580-591. https://doi.org/10.1002/ana.23944
  7. Jani BD, McLean G, Nicholl BI, et al. Risk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkers. Front Hum Neurosci. 2015;9:18. https://doi.org/10.3389/fnhum.2015.00018
  8. Hek K, Demirkan A, Lahti J, Terracciano A. A genome-wide association study of depressive symptoms. Biol Psychiatry. 2013;73:667-778. https://doi.org/10.1016/j.biopsych.2012.09.033
  9. Lewis CM, Ng MY, Butler AW, Cohen-Woods S, Uher R, Pirlo K, et al. Genome-wide association study of major recurrent depression in the UK population. Am J Psychiatry. 2010;167:949-957. https://doi.org/10.1176/appi.ajp.2010.09091380
  10. Wray NR, Pergadia ML, Blackwood DHR, Penninx BWJH, Gordon SD, Nyholt DR, et al. Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. Mol Psychiatry. 2012;17:36-48. https://doi.org/10.1038/mp.2010.109
  11. Shi J, Potash JB, Knowles JA, Weissman MM, Coryell W, Scheftner WA, et al. Genome-wide association study of recurrent early-onset major depressive disorder. Mol Psychiatry. 2011;16:193-201. https://doi.org/10.1038/mp.2009.124
  12. Ripke S, Daly J, Lewis CM, Lin D, Wray NR, Neale B, et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry. 2013;18:497-511. https://doi.org/10.1038/mp.2012.21
  13. Mullins N, Lewis CM. Genetics of Depression: Progress at Last. Curr Psychiatry Rep. 2017;19:43. https://doi.org/10.1007/s11920-017-0803-9
  14. Serretti A. Genetics and pharmacogenetics of mood disorders. Psychiatr Pol. 2017;51(2):197-203. https://doi.org/10.12740/PP/68914
  15. Hicks J, Bishop J, Sangkuhl K, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. Clinical Pharmacology and Therapeutics. 2015;98(2):127-134. https://doi.org/10.1002/cpt.147
  16. Table of Pharmacogenomic Biomarkers in Drug Labeling. http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm083378.htm
  17. Trivedi MH. Right patient, right treatment, right time: biosignatures and precision medicine in depression World Psychiatry. 15:3. 2016;237-238. https://doi.org/10.1002/wps.20371
  18. Fried EI, Nesse RM. Depression sum-scores don’t add up: why analyzing specific depression symptoms is essential. BMC Med. 2015;13:1-11. https://doi.org/10.1186/s12916-015-0325-4
  19. International Statistical Classification of Diseases and Related Health Problems 10th Revision.http://apps.who.int/classifications/icd10/browse/2010/en#/F30-F39
  20. Krasnov VN. Problems of current diagnosis of depression. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova (Special issues). 2012;112(11):3-10. (In Russ.)
  21. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). https://www.psychiatry.org/psychiatrists/practice/dsm
  22. Ghaemi SN, Vöhringer PA. The heterogeneity of depression: an old debate renewed. Acta Psychiatr Scand. 2011;124(6):497. https://doi.org/10.1111/j.1600-0447.2011.01746.x
  23. Rush AJ. The varied clinical presentations of major depressive disorder. J Clin Psychiatry. 2007;68:4-10.
  24. van Loo HM, de Jonge P, et al. Data-driven subtypes of major depressive disorder: a systematic review. BMC Medicine. 2012;10:156. https://doi.org/10.1186/1741-7015-10-156
  25. van Loo HM. Data-driven subtypes of major depressive disorder. [Groningen]: University of Groningen. 2015. https://doi.org/10.1016/j.jad.2015.03.045
  26. Baumeister H, Parker G. Meta-review of depressive subtyping models. J Affect Disord. 2012;139(2):126-140. https://doi.org/10.1016/j.jad.2011.07.015
  27. Krasnov VN. Problems of diagnosis and classification in russian-speaking psychiatry: section of affective spectrum disorders. Sotsial’naya i Klinicheskaya Psikhiatriya. 2010;4:58-63. (In Russ.)
  28. Uher R, Muthén B, Souery D, Mors O, Jaracz J, Placentino A, Petrovic A, Zobel A, Henigsberg N, Rietschel M, Aitchison KJ, Farmer A, McGuffin P: Trajectories of change in depression severity during treatment with antidepressants. Psychol Med. 2010;40:1367-1377. https://doi.org/10.1017/s0033291709991528
  29. Elhai JD, Naifeh JA, Forbes D, Ractliffe KC, Tamburrino M: Heterogeneity in clinical presentations of posttraumatic stress disorder among medical patients: testing factor structure variation using factor mixture modeling. J Trauma Stress. 2011;24:435-443. https://doi.org/10.1002/jts.20653
  30. Marquand AF, Wolfers T, Mennes M, Buitelaar J, Beckmann CF. Beyond Lumping and Splitting: A Review of Computational Approaches for Stratifying Psychiatric Disorders. Biological Psychiatry. 2016;1(5):433-447. https://doi.org/10.1016/j.bpsc.2016.04.002
  31. Pituch KA, Stevens JP. Applied multivariate statistics for the social sciences. Sixth edition. New York, NY US: Routledge/Taylor & Francis Group; 2016.
  32. Bureeva NN. Multidimensional statistical analysis using «Statistica». Educational and methodological material on the program of advanced training «Application of software in scientific research and teaching of mathematics and mechanics». Nizhnii Novgorod. 2007. (In Russ.)
  33. Lanza ST, Rhoades BL. Latent Class Analysis: An Alternative Perspective on Subgroup Analysis in Prevention and Treatment. Prev Sci. 2013;14(2):157-168. https://doi.org/10.1007/s11121-011-0201-1
  34. Kochenkov AI, Tolstova YuN. Ideas of Lazarsfeld’s latent-structural analysis in modern sociology. Sotsiologiya: Metodologiya, Metody, Matematicheskoe Modelirovanie. 2003;16:127-149. (In Russ.)
  35. Lamers F, de Jonge P, Nolen WA, Smit JH, Zitman FG, Beekman ATF. Identifying depressive subtypes in a large cohort study: Results from the Netherlands Study of Depression and Anxiety (NESDA) J Clin Psychiatry. 2010;71:1582-1589. https://doi.org/10.4088/jcp.09m05398blu
  36. Milaneschi Y, Lamers F, Peyrot WJ, Abdellaoui A, Willemsen G, Hottenga JJ. Polygenic dissection of major depression clinical heterogeneity. Mol Psychiatry. 2015;21:516-522. https://doi.org/10.1038/mp.2015.86
  37. de Jonge P, Mangano D, Whooley MA. Differential association of cognitive and somatic depressive symptoms with heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. Psychosom Med. 2007;69:735-739. https://doi.org/10.1097/psy.0b013e31815743ca
  38. Roest AM, Thombs BD, Grace SL, Stewart DE, Abbey SE, de Jonge P. Somatic/affective symptoms, but not cognitive/affective symptoms, of depression after acute coronary syndrome are associated with 12-month all-cause mortality. J Affect Disord. 2011;131:158-163. https://doi.org/10.1016/j.jad.2010.11.018
  39. Van Praag HM. Kraepelin, biological psychiatry, and beyond. European Archives of Psychiatry and Clinical Neuroscience. 2008;258(2):29-32. https://doi.org/10.1007/s00406-008-2006-1
  40. Morley S, Williams AC, Black S. A confirmatory factor analysis of the Beck Depression Inventory in chronic pain. Pain. 2002;99(1-2):289-298. https://doi.org/10.1016/s0304-3959(02)00137-9
  41. McNally RJ, Robinaugh DJ, Wu GW, Wang L, Deserno MK, Borsboom D. Mental disorders as causal systems: A network approach to Posttraumatic Stress Disorder. Clinical Psychological Science. 2014:1-14. https://doi.org/10.1177/2167702614553230
  42. Borsboom D, Epskamp S, Kievit RA, Cramer AO, Schmittmann VD. Transdiagnostic Networks Commentary on Nolen-Hoeksema and Watkins 2011. Perspectives on Psychological Science. 2011;6(6):610-614. https://doi.org/10.1177/1745691611425012
  43. Borsboom D, Cramer AO. Network analysis: an integrative approach to the structure of psychopathology. Annual Review of Clinical Psychology. 2013;9:91-121. https://doi.org/10.1146/annurev-clinpsy-050212-185608
  44. Schmittmann VD, Cramer AO, Waldorp LJ, Epskamp S, Kievit RA, Borsboom D. Deconstructing the construct: A network perspective on psychological phenomena. New Ideas in Psychology. 2013;31(1):43-53. https://doi.org/10.1016/j.newideapsych.2011.02.007
  45. Fried EI. Moving forward: how depression heterogeneity hinders progress in treatment and research. Expert Review of Neurotherapeutics. 2017;17:5:423-425. https://doi.org/10.1080/14737175.2017.1307737
  46. Borsboom D. A network theory of mental disorders. World Psychiatry. 2017;16(1):5-13. https://doi.org/10.1002/wps.20375
  47. Borsboom D. Psychometric perspectives on diagnostic systems. J Clin Psychol. 2008;64:1089-1108. https://doi.org/10.1002/jclp.20503
  48. Cramer AOJ, Waldorp LJ, van der Maas HLJ, et al. Comorbidity: a network perspective. Behav Brain Sci. 2010;33:137-193. https://doi.org/10.1017/s0140525x09991567
  49. Fried EI, Nesse RM, et al. Depression is more than the sum-score of its parts: individual DSM symptoms have different risk factors. Psychol Med. 2014;44(10):2067-2076. https://doi.org/10.1017/S0033291713002900
  50. Jang KL, Livesley WJ, Taylor S, Stein MB, Moon EC. Heritability of individual depressive symptoms. J Affect Disord. 2004;80:125-133. https://doi.org/10.1016/s0165-0327(03)00108-3
  51. Myung W, Song J, Lim S-W, Won H-H, Kim S, Lee Y, et al. Genetic association study of individual symptoms in depression. Psychiatry Res. 2012;198:400-406. https://doi.org/10.1016/j.psychres.2011.12.037
  52. Uher R, Perlis RH, Henigsberg N, Zobel A, Rietschel M, Mors O, et al. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychol Med. 2011;42:967-980. https://doi.org/10.1017/s0033291711001905
  53. Colman I, Naicker K, Zeng Y, Ataullahjan A, Senthilselvan A, Patten SB. Predictors of long-term prognosis of depression. Can Med Assoc J. 2011;183:1955-1956. https://doi.org/10.1503/cmaj.110676
  54. Fried EI, Epskamp S, Nesse RM, et al. What are ‘good’ depression symptoms? Comparing the centrality of DSM and non-DSM symptoms of depression in a network analysis. J Affect Disord. 2016;189:314-320. https://doi.org/10.1016/j.jad.2015.09.005
  55. Wichers M, Groot P, Simons CJP, et al. Critical slowing down as a personalized early warning signal for depression. Psychother Psychosom. 2016;85:114-116. https://doi.org/10.1159/000441458
  56. Boschloo L, van Borkulo CD, Borsboom D, et al. A prospective study on how symptoms in a network predict the onset of depression. Psychother Psychosom. 2016;85:183-184. https://doi.org/10.1159/000442001
  57. Beard C, Millner AJ, et al. Network Analysis of Depression and Anxiety Symptom Relations in a Psychiatric Sampl. Psychol Med. 2016;46(16):3359-3369. https://doi.org/10.1017/S0033291716002300
  58. Cuthbert BN. The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry. 2014;13:28-35. https://doi.org/10.1002/wps.20087
  59. Maj M. Keeping an open attitude toward the RDoC project. World Psychiatry. 2014;13:1-2. https://doi.org/10.1002/wps.20111
  60. Primo de Carvalho Alves L, Pio de Almeida Fleck M, Boni A, Sica da Rocha N. The Major Depressive Disorder Hierarchy: Rasch Analysis of 6 items of the Hamilton Depression Scale Covering the Continuum of Depressive Syndrome. Vrana KE, ed. PLoS ONE. 2017;12(1):e0170000. https://doi.org/10.1371/journal.pone.0170000
  61. Fried EI, van Borkulo CD, Epskamp S, et al. Measuring depression over time or not? Lack of unidimensionality and longitudinal measurement invariance in four common rating scales of depression. Psychol Assess. 2016;28:1354-1367. https://doi.org/10.1037/pas0000275
  62. Avdeeva TI, Ivanets NN, Kinkulkina MA. Depressive disorders in elderly patients: an attempt of psychometric assessment with the Montgomery—Asberg Depression Rating Scale. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova (Special issues). 2012;112(8):56-62. (In Russ.)
  63. A paradigm shift in psychiatric classification: the Hierarchical Taxonomy Of Psychopathology (HiTOP). World Psychiatry. 17:1. https://doi.org/10.1002/wps.20478
  64. Kotov R, Krueger RF, et al. The Hierarchical Taxonomy of Psychopathology (HiTOP): A dimensional alternative to traditional nosologies. J Abnorm Psychol. 2017;126(4):454-477. https://doi.org/10.1037/abn0000258
  65. NIMH Research Domain Criteria (RDoC). https://www.nimh.nih.gov/research-priorities/rdoc/index.shtml
  66. Cuthbert B, Insel T. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 2013;11:126-135. https://doi.org/10.1186/1741-7015-11-126
  67. Maj M. Narrowing the gap between ICD/DSM and RDoC constructs: possible steps and caveats. World Psychiatry. 2016;15(3):193-194. https://doi.org/10.1002/wps.20370
  68. Phillips MR. Will RDoC hasten the decline of America’s global leadership role in mental health? World Psychiatry. 2014;13:40-41. https://doi.org/10.1002/wps.20098
  69. Wakefield JC. Wittgenstein’s nightmare: why the RDoC grid needs a conceptual dimension. World Psychiatry. 2014;13:38-39. https://doi.org/10.1002/wps.20097
  70. Frances A. RDoC is necessary, but very oversold. World Psychiatry. 2014;13:48-49. https://doi.org/10.1002/wps.20102
  71. Fava GA. Road to nowhere. World Psychiatry. 2014;13:49. https://doi.org/10.1002/wps.20108

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.